Vernalis plc (LSE: VER) today announces it has opened its US office in Berwyn, Pennsylvania and has strengthened its US Executive team with the appointment of Dr Pascal Borderies, as SVP Medical Affairs. A physician by training, Pascal joins Vernalis from Actavis' subsidiary
Vernalis
Breaking News
Vernalis is pleased to announce the achievement of the first milestone in its research collaboration with Asahi Kasei Pharma (AKP).